BSE filing, NSE: SANDUPHQ. Summary written from the filing by ALFA Finder's alert engine.
Sandu Pharmaceuticals Ltd: key numbers
- Share price
- ₹35.00
- Market cap
- ₹33.81 Cr
- Revenue (annual)
- ₹69.93 Cr
- Net profit (annual)
- ₹1.77 Cr
- P/E (TTM)
- 13.9×Sector 45.9×
- Promoter holding
- 37.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandu Pharmaceuticals Ltd
All →Sandu Pharmaceuticals Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals intimated that Non-Executive Independent Director Dr Neeti Madan Kapre has changed her name to Dr Neeti Gupta after marriage. The DIN, designation and directorship remain unchanged.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals Limited has issued a reminder to physical shareholders regarding the mandatory submission of PAN and KYC details. This compliance follow-up aims to facilitate electronic dividend payments.
Sandu Pharmaceuticals Management Change
Sandu Pharmaceuticals appointed Dr. Neeti Madan Kapre as director and Dave & Dave as statutory auditor, while announcing other board and auditor tenure changes.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals has appointed M/s. Dave & Dave as Statutory Auditors for a five-year term, following the tenure expiry of the previous auditors.
Sandu Pharmaceuticals Annual General Meeting
Sandu Pharmaceuticals Limited held its 41st Annual General Meeting on September 11, 2026, via video conferencing to transact ordinary and special business items.
Other debt & borrowing announcements
All →Regency Fincorp Debt & Borrowing: ₹0.1 Cr
Regency Fincorp paid Rs.0.10 Crore monthly interest on its 15% secured NCDs on November 1, 2026. The payment was made on the due date with no delay.
- Value
- ₹0.10 Cr
State Bank of India Debt & Borrowing: ₹781 Cr
SBI paid ₹781 Crore annual interest on its Basel III Tier 2 bonds on 2 November 2026. No delay or change in payment frequency was reported.
- Value
- ₹781.0 Cr
QGO Finance Debt & Borrowing: ₹1.25 Cr
QGO Finance redeemed 125 unsecured NCDs worth Rs 1.25 Crore on November 2, 2026, with interest paid. The holder requested redemption after the lock-in period.
- Value
- ₹1.25 Cr
Muthoot Finance Debt & Borrowing: ₹2.32 Cr
Muthoot Finance paid monthly interest of Rs.2.32 Crore across nine secured NCD series on November 2, 2026. The payments were made one day after the November 1 due date.
- Value
- ₹2.32 Cr
Aptus Value Housing Finance India Debt & Borrowing: ₹0.89 Cr
Aptus Value Housing paid Rs.0.89 Crore monthly interest on its NCDs (ISIN INE852O07162) on 2 November 2026. The payment fulfils the scheduled coupon on Rs.150 Crore secured debentures.
- Value
- ₹0.89 Cr
HDB Financial Services Debt & Borrowing: ₹26.2 Cr
HDB Financial Services paid ₹26.20 Crore of interest on its Series 2024/18 subordinate bonds on 2 November 2026. This is routine servicing of existing debt obligations.
- Value
- ₹26.20 Cr